EX-23.1 7 f20f2021ex23-1_neurosense.htm CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the registration statement (No. 333-262480) on Form S-8 of our report dated April 14, 2022, with respect to the financial statements of Neurosense Therapeutics Ltd.

 

/s/ Somekh Chaikin  
Somekh Chaikin  
Member Firm of KPMG International  
Tel Aviv, Israel  
April 14, 2022